Literature DB >> 1377953

Combination of recombinant cytokines fails to produce ex vivo expansion of human blood hematopoietic progenitor cells.

Y Takaue1, T Abe, Y Kawano, A Hirao, A Yokobayashi, Y Okamoto, S Saito, T Shimizu, J Sato, T Watanabe.   

Abstract

The concept of ex vivo expansion of the human progenitor cell population was tested in this study. In the presence of interleukin-3 and -6 we compared the abilities of various liquid culture conditions of human blood-derived hematopoietic progenitor cells to yield a suitable condition for the expansion of blood progenitor cells. Although the best result was obtained in the gastpermeable bag culture system, the enhancement effect (maximum of 3.8-fold for granulocyte/macrophage colony-forming units and 3.0-fold for erythroid burst-forming units) lasted for only a short period (less than 6 d). The results of this study are disappointing for clinical use, and attempts with currently available technology appear to be limited in their potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377953     DOI: 10.1007/bf01738299

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Effects of various recombinant human hemopoietic growth factors (rhEpo, rhG-CSF, rhGM-CSF, rhIl-3) on the growth of peripheral blood progenitor cells (BFU-E, CFU-GM).

Authors:  S Serke; D Huhn
Journal:  Blut       Date:  1990-07

2.  Blood-derived haematopoietic cell transplants: blood to blood?

Authors:  P R Henon; A Butturini; R P Gale
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

3.  Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer.

Authors:  Y Takaue; T Watanabe; Y Kawano; T Koyama; T Abe; T Suzue; J Satoh; T Shimokawa; T Ninomiya; M Kosaka
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

4.  Differential activity of recombinant colony-stimulating factors in supporting proliferation of human peripheral blood and bone marrow myeloid progenitors in culture.

Authors:  D Caracciolo; S Clark; G Rovera
Journal:  Br J Haematol       Date:  1989-07       Impact factor: 6.998

5.  Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha.

Authors:  M Takahashi; K Oshimi; H Mizoguchi
Journal:  Exp Hematol       Date:  1990-06       Impact factor: 3.084

6.  Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

Authors:  T Murase; T Hotta; H Saito; R Ohno
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

7.  In vitro expansion of the murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6. Application to bone marrow transplantation.

Authors:  A Okano; C Suzuki; F Takatsuki; Y Akiyama; K Koike; K Ozawa; T Hirano; T Kishimoto; T Nakahata; S Asano
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

8.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

9.  Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3.

Authors:  G Kannourakis; G R Johnson
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

10.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  1 in total

1.  Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.

Authors:  T A McAdams; C E Sandstrom; W M Miller; J G Bender; E T Papoutsakis
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.